Antimicrobial peptides and their expanding role in the management of surgical site infections
Year: 2026
Type: article
Abstract: Postoperative care is a critical phase of patient recovery, frequently complicated by surgical site infections (SSIs) and delayed wound healing. The growing burden of antimicrobial resistance (AMR) further compromises the effectiveness of conventional antibiotics, highlighting the need for alternative therapeutic strategies. Antimicrobial peptides (AMPs), including LL-37, human β-defensins (hBDs), magainins, and cecropins, have emerged as promising candidates due to their broad-spectrum antimicrobial activity and multifunctional biological roles. These peptides are effective against multidrug-resistant pathogens while simultaneously promoting wound healing through enhanced re-epithelialization, angiogenesis, and immune modulation. In addition to their direct antimicrobial effects, AMPs can disrupt biofilm formation and regulate inflammatory responses, both of which are critical in the pathogenesis of chronic and postoperative wound infections. Their incorporation into advanced delivery systems, including hydrogels, nanofibers, and antimicrobial coatings for surgical materials, further enhances their clinical applicability. Despite these advantages, challenges such as proteolytic instability, potential cytotoxicity, and high production costs limit their widespread clinical use. Future research should focus on improving peptide stability, optimizing delivery platforms, and ensuring safety to facilitate clinical translation. Overall, the integration of AMPs into postoperative care represents a promising and innovative strategy to prevent infections, accelerate wound healing, and reduce reliance on traditional antibiotics in the era of increasing AMR.
Source: Discover Medicine
Language: English
Subfield: Microbiology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: antimicrobial peptides, surgical site infection, surgical wound healing, antimicrobial resistance, LL-37, human beta-defensins, magainin, cecropin, biofilm eradication, re-epithelialization, angiogenesis, wound inflammation, hydrogels, nanofibers, antimicrobial coatings, peptide stability, cytotoxicity
Open Access status: gold
Estimated APC paid: $1,290
OpenAlex ID: W7226007389
